Amerigen to Commercialize Two of Inventia's ANDA's

Monday, September 23, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LYNDHURST, N.J. and MUMBAI, India, Sept. 23, 2019 /PRNewswire/ -- Amerigen Pharmaceuticals Limited ("Amerigen") and Inventia Healthcare Limited ("Inventia") today announced they had entered into a collaboration involving two of Inventia's recently approved U.S. ANDA's. Under the terms of the collaboration agreement, Amerigen will be the exclusive

U.S. commercial partner for Inventia's paliperidone extended-release tablets and tolterodine extended-release capsules. Amerigen's U.S. affiliate, Amerigen Pharmaceuticals, Inc., shall be responsible for sales, marketing and distribution for the two products, which shall be manufactured and supplied by Inventia.

About Amerigen:Amerigen Pharmaceuticals is a group of companies engaged in all phases of the generic pharmaceutical business, with operations in the US and China. The group is controlled by Amerigen Pharmaceuticals Limited. The US regulatory and commercial activities within the group are conducted by Amerigen Pharmaceuticals Inc., based in Lyndhurst, NJ, USA.

About Inventia:Inventia Healthcare Limited is a company headquartered in Mumbai, India; with marketing partners across 28 countries for niche generic oral solid products.

Cision View original content:http://www.prnewswire.com/news-releases/amerigen-to-commercialize-two-of-inventias-andas-300922606.html

SOURCE Amerigen Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store